SKI Market

A+| A| A-|

Indian Indices

Sensex

76,913.50 -582.86
( -0.75%)

Global Indices

Nasdaq

49,692.16 809.34
(1.66%)

Dow Jones

7,235.98 79.03
(1.10%)

Hang Seng

59,594.47 309.55
(0.52%)

Nikkei 225

10,375.34 -3.48
(-0.03%)

Forex

USD-INR

94.79 0.27
(0.29%)

EUR-INR

110.85 0.20
(0.18%)

GBP-INR

127.93 0.23
(0.18%)

JPY-INR

0.59 0.00
(-0.01%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Sun Pharmaceutical Industries Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

524715

INE044A01036

99.2482659

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

SUNPHARMA

99.41

433847.75

EPS(TTM)

Face Value()

Div & Yield %

18.19

0.88

Back

ajanta pharma ltd

Ajanta Pharma's Paithan unit concludes USFDA inspection

Apr 22,2026

Ajanta Pharma announced that the USFDA has concluded an inspection at its manufacturing facility at Paithan, in Maharashtra. The Inspection was conducted from 13 April 2026, to 21 April 2026, and closed with the issuance of Form-483 with 5 (five) observations.

76,913.50 -582.86 ( -0.75%)

49,692.16 809.34 (1.66%)

7,235.98 79.03 (1.10%)

59,594.47 309.55 (0.52%)

10,375.34 -3.48 (-0.03%)

94.79 0.27 (0.29%)

110.85 0.20 (0.18%)

127.93 0.23 (0.18%)

0.59 0.00 (-0.01%)